Tirzepatide 375 CU50 CU100 NJ100 NJ500 RT5 RT10 RT15 CAS2023788-19-2
TDS 15 Inquiries
682809-81-0
Pharmaceutical Grade
99%
shenzhen
sc
5 mg / 10 mg / 20 mg. 10 bottles per box
Yes
2028-05-01
tr
-
Product Details
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceAHK-Cu, also known as Alanine-Histidine-Lysine-Copper, is a synthetic peptide that has garnered significant attention in recent years due to its potential applications in various fields, particularly in dermatology and regenerative medicine. Peptides are short chains of amino acids, and when combined with copper ions, they can exhibit unique biological activities.Certificates
-
TDS
Basic Info-
Product Name:
AHK-Cu
Other Name:ALA-HIS-LYS-CU;Copper Peptide 1:1;L-Alanyl-κN-L-histidyl-κN,κN3-L-lysinato(2-)]copper Monohydrochloride;AHK-Cu(2:1);ALA-HIS-LYS-CU(AHK-Cu);ACETYILHEXAPEPTIDE-8
CAS No.:682809-81-0
Molecular Formula:C15H24ClCuN6O4
InChIKeys:ZVDTZHLNTORZAU-FBSJPIKRNA-L
Molecular Weight:451.39
Categories:
Research-
Class:
Dual agonist — GIPR, GLP-1R
Status:FDA-approved (Mounjaro / Zepbound)
Mechanism:Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.
EC50 (Human GLP1R):0.934 nM
EC50 (Human GIPR):0.0224 nM
Source:Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI
Clinical Development:NCT03954834; NCT03987919; NCT03882970; NCT03730662; NCT04039503
FDA:Mounjaro, Zepbound (approved 2022-05-13)
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Disclaimer:
Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
tr
-
Location:
B27 SHING LEE COMM BLDG 8WING KUT ST CENTRAL HONGKONG
-
Average lead Time:
1 days
-
Total Annual Revenue:
Less than $1 million
-
Total Employees:
5-10
-
Year of Establishment:
2026
-
-
Inquiry History15 Inquiries
Country Product Purchase Quantity Date Posted
United States
AHK-Cu
1 MT Oct 18, 2026
Philippines
AHK-Cu
10 MG Sep 8, 2026
United States
Raw ahk-cu
5 G Sep 2, 2026
United States
AHK-CU
100 BOU Aug 31, 2026
United Kingdom
AHK-CU
5 G Aug 9, 2026
United States
AHK-Cu
10 PCS Jul 16, 2026
United States
AHK-CU
20 G Jun 29, 2026
United States
Ahk-cu
20 MT Jun 14, 2026
United States
Ahk-cu
100 MT Apr 24, 2026
United States
AHK-cu
1 MT Mar 17, 2026
Sweden
GHK-Cu
1 KG Mar 17, 2026
United States
AHK-Cu Directly Supply Bottom Price CAS 682809-81-0 Cosmetic Copper Peptide ghk-cu
1 MT Feb 5, 2026
United States
AHK cu
1 KG Dec 15, 2025
United States
Ahk-cu
1 MT Nov 8, 2025
United States
AHK-Cu
1 KG Nov 6, 2025 Post an enquiry for this product
More from this Seller
-
-
-
GT600(Brand) AOD SM5 MS10 NJ500 G5K SK10 TR15 IP5 BC5 MS40
Pharmaceutical Grade / 99%
$1/G FOB
-
-
-
-
TB500 LL37 GHK-CU BT5 BT10 375 CU50 CU100 NAD+ NJ100 NJ500 NJ1000 Manufacturer's price
Pharmaceutical Grade / 99%
$1/G FOB
-
-
-
-
Asetic Acid water - Medical grade, raw material, high purity, available in stock
Pharmaceutical Grade / 99%
$1/G FOB
-
-
-
-
TR50 TR60 RT5 RT10 RT15 NJ500 NJ1000 GT600(Brand) GT1500 CGL5 CAS154947-66-7 Glutathione cagrilintide
Pharmaceutical Grade / 99%
$1/G FOB
-
-
-
-
TR5 TR10 TR15 TR20 TR30 TR40 TR50 TR60 SM2 SM5 SM10 SM15 SM20 SM30 Semaglutide Tirzepatide Retatrutide Recombinant peptide
Pharmaceutical Grade / 99%
$1/G FOB
-
-
-
-
Tirzepatide GT1500 CGL5 CGL10 NP810 XA5 MS10 MS40 322 ET10 ET50 Thymosin Alpha-1
Pharmaceutical Grade / 99%
$1/G FOB
-
